National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 1) (PB 2 of 2019) (Cth)

PB 2 of 2019

National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 1)

National Health Act 1953

___________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated      29 January 2019

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 1).

(2)This Instrument may also be cited as PB 2 of 2019.

1. Commencement

This Instrument commences on 1 February 2019.

1. Amendment of National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1       Amendments

1. Schedule 1, entry for Glyceryl trinitrate

(a)omit:

Glyceryl trinitrate Transdermal patch 120 mg 20 30 5

(b)omit:

Glyceryl trinitrate Transdermal patch 40 mg 20 30 5

(c)omit:

Glyceryl trinitrate Transdermal patch 80 mg 20 30 5

1. Schedule 1, omit entry for Paritaprevir with ritonavir with ombitasvir and dasabuvir

1. Schedule 1, omit entry for Paritaprevir with ritonavir with ombitasvir and dasabuvir and ribavirin